Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker PTHS
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Ezra M. Friedberg Director | PTHS Pelthos Therapeutics Inc. | Sale | 24 | $27.33 | $656 Sale | Form 4 ↗ |
| Jul 2, 2026 | Ezra M. Friedberg Director | PTHS Pelthos Therapeutics Inc. | Sale | 534 | $26.03 | $13.9K Sale | Form 4 ↗ |
| Jul 2, 2026 | Matthew Pauls Director | PTHS Pelthos Therapeutics Inc. | Sale | 94 | $27.36 | $2,572 Sale | Form 4 ↗ |
| Jul 2, 2026 | Matthew Pauls Director | PTHS Pelthos Therapeutics Inc. | Sale | 692 | $26.00 | $18.0K Sale | Form 4 ↗ |
| Jul 2, 2026 | Peter Greenleaf Director | PTHS Pelthos Therapeutics Inc. | Sale | 85 | $27.27 | $2,318 Sale | Form 4 ↗ |
| Jul 2, 2026 | Peter Greenleaf Director | PTHS Pelthos Therapeutics Inc. | Sale | 712 | $26.00 | $18.5K Sale | Form 4 ↗ |
| Jun 15, 2026 | Ezra M. Friedberg Director | PTHS Pelthos Therapeutics Inc. | Sale | 59 | $27.94 | $1,648 Sale | Form 4 ↗ |
| Jun 15, 2026 | Ezra M. Friedberg Director | PTHS Pelthos Therapeutics Inc. | Sale | 224 | $27.12 | $6,075 Sale | Form 4 ↗ |
| Jun 11, 2026 | Todd C. Davis Director | PTHS Pelthos Therapeutics Inc. | Buy | 503 | $28.73 | $14.5K Buy | Form 4 ↗ |
| Jun 11, 2026 | Todd C. Davis Director | PTHS Pelthos Therapeutics Inc. | Buy | 35,445 | $27.80 | $985.4K Buy | Form 4 ↗ |
| May 22, 2026 | Knuettel Francis II CFO, Treas & Secty | PTHS Pelthos Therapeutics Inc. | Sale | 1,500 | $26.84 | $40.3K Sale | Form 4 ↗ |
| Apr 2, 2026 | Richard Malamut Director | PTHS Pelthos Therapeutics Inc. | Sale | 280 | $21.36 | $5,981 Sale | Form 4 ↗ |
| Apr 2, 2026 | Richard Malamut Director | PTHS Pelthos Therapeutics Inc. | Sale | 310 | $20.51 | $6,358 Sale | Form 4 ↗ |
| Apr 2, 2026 | Ezra M. Friedberg Director | PTHS Pelthos Therapeutics Inc. | Sale | 265 | $21.36 | $5,660 Sale | Form 4 ↗ |
| Apr 2, 2026 | Ezra M. Friedberg Director | PTHS Pelthos Therapeutics Inc. | Sale | 293 | $20.51 | $6,009 Sale | Form 4 ↗ |
| Apr 2, 2026 | Matthew Pauls Director | PTHS Pelthos Therapeutics Inc. | Sale | 371 | $21.36 | $7,925 Sale | Form 4 ↗ |
| Apr 2, 2026 | Matthew Pauls Director | PTHS Pelthos Therapeutics Inc. | Sale | 415 | $20.52 | $8,516 Sale | Form 4 ↗ |
| Apr 2, 2026 | Peter Greenleaf Director | PTHS Pelthos Therapeutics Inc. | Sale | 377 | $21.36 | $8,053 Sale | Form 4 ↗ |
| Apr 2, 2026 | Peter Greenleaf Director | PTHS Pelthos Therapeutics Inc. | Sale | 420 | $20.52 | $8,618 Sale | Form 4 ↗ |
| Nov 25, 2025 | Ezra M. Friedberg Director | PTHS Pelthos Therapeutics Inc. | Sale | 2,000 | $28.01 | $56.0K Sale | Form 4 ↗ |
| Nov 25, 2025 | Ezra M. Friedberg Director | PTHS Pelthos Therapeutics Inc. | Sale | 1 | $28.50 | $28.5 Sale | Form 4 ↗ |
| Nov 25, 2025 | Ezra M. Friedberg Director | PTHS Pelthos Therapeutics Inc. | Sale | 2,000 | $28.14 | $56.3K Sale | Form 4 ↗ |
| Nov 25, 2025 | Ezra M. Friedberg Director | PTHS Pelthos Therapeutics Inc. | Sale | 5,999 | $28.00 | $168.0K Sale | Form 4 ↗ |
23 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:33 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances